Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:THRN Thorne HealthTech (THRN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Thorne HealthTech Stock (NASDAQ:THRN) 30 days 90 days 365 days Advanced Chart Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Thorne HealthTech alerts:Sign Up Key Stats Today's Range$10.19▼$10.1950-Day Range$10.13▼$10.2052-Week Range$3.41▼$10.20VolumeN/AAverage Volume110,986 shsMarket Capitalization$549.44 millionP/E Ratio26.82Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewThorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.Read More… Receive THRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter. Email Address THRN Stock News HeadlinesAuburn QB Payton Thorne gets Venmo requests from angry fans after brutal performancesSeptember 12, 2024 | nypost.comDr. Gary A. ThorneFebruary 22, 2024 | health.usnews.comForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedDecember 23, 2024 | DTI (Ad)Lisa D. ThorneFebruary 3, 2024 | health.usnews.comTHORNE HEALTHTECH ANNOUNCES INNOVATION ARM UNDER THORNE VENTURESDecember 22, 2023 | morningstar.comBella Thorne, OnlyFans and the battle over monetising contentDecember 8, 2023 | bbc.comDr. Doris K. ThorneNovember 17, 2023 | health.usnews.comL Catterton Completes Acquisition of Thorne HealthTech, Inc.October 16, 2023 | finance.yahoo.comSee More Headlines THRN Stock Analysis - Frequently Asked Questions How were Thorne HealthTech's earnings last quarter? Thorne HealthTech, Inc. (NASDAQ:THRN) announced its quarterly earnings data on Wednesday, November, 10th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.03. The company earned $48.01 million during the quarter. Thorne HealthTech had a trailing twelve-month return on equity of 9.03% and a net margin of 7.84%. When did Thorne HealthTech IPO? Thorne HealthTech (THRN) raised $98 million in an initial public offering (IPO) on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share. What other stocks do shareholders of Thorne HealthTech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Thorne HealthTech investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON) and Jabil (JBL). Company Calendar Last Earnings11/10/2021Today12/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Defensive Industry Packaged Foods Sub-IndustryN/A Current SymbolNASDAQ:THRN CUSIPN/A CIK1844280 Webwww.thorne.com Phone929-251-6321FaxN/AEmployees544Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.38 Trailing P/E Ratio26.82 Forward P/E Ratio35.14 P/E GrowthN/ANet Income$15.67 million Net Margins7.84% Pretax Margin5.59% Return on Equity9.03% Return on Assets5.57% Debt Debt-to-Equity Ratio0.16 Current Ratio2.41 Quick Ratio1.13 Sales & Book Value Annual Sales$228.73 million Price / Sales2.40 Cash Flow$0.26 per share Price / Cash Flow39.41 Book Value$2.78 per share Price / Book3.67Miscellaneous Outstanding Shares53,920,000Free Float13,480,000Market Cap$549.44 million OptionableOptionable Beta0.82 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report This page (NASDAQ:THRN) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thorne HealthTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thorne HealthTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.